Abd El-Rahman Ahmad M, Khalaf Saif Eldeen Gamal, Bakri Mohamed H
Department of Anaesthesia, Pain, and ICU, South Egypt Cancer Institute, Assiut University, Assiut, Egypt.
Department of Anaesthesia, Pain, and ICU, Faculty of Medicine, Assiut University, Assiut, Egypt.
Local Reg Anesth. 2025 Aug 18;18:57-66. doi: 10.2147/LRA.S515752. eCollection 2025.
In the light of the abundance of various analgesic methods available for analgesia following modified radical mastectomy (MRM) (pharmacological or interventional), we aimed to try a very simple technique using a drug combination (ketamine-bupivacaine) through wound instillation and to compare it to the reputable PECS-II block using the same drug combination. We hypothesized that, with this drug combination, local instillation may achieve a comparable, long lasting, analgesia for almost 48 hours, with less costly, and simple method.
Sixty women scheduled to undergo MRM participated in this study. Patients were randomized to have either; ultrasound-guided, modified PECS block (PECS group), or instillation of analgesics into the surgical wound (local instillation group). In both groups, we used 1 mg/kg ketamine HCL plus 0.25% bupivacaine HCL in a 30 mL volume. Total consumption of rescue morphine, time to 1 analgesic request, numerical rating scale (NRS), hemodynamic effects were recorded over 48 hours postoperatively. In addition, the time required to perform either technique and possible side effects were recorded.
Total consumption of rescue morphine, first analgesic request, pain scores, showed no statistically significant differences in both groups; the local instillation procedure required a statistically significant shorter time to perform than the PECS procedure. None of the groups showed significant differences in the incidence of adverse effects.
Local wound instillation provided a comparable analgesia to PECS-II block following modified radical mastectomy. Ketamine-bupivacaine combination prolonged analgesia for almost 2 days.
鉴于改良根治性乳房切除术(MRM)后有多种镇痛方法(药物或介入性)可供选择,我们旨在尝试一种非常简单的技术,即通过伤口滴注使用药物组合(氯胺酮-布比卡因),并将其与使用相同药物组合的著名的PECS-II阻滞进行比较。我们假设,使用这种药物组合,局部滴注可能会在近48小时内实现类似的、持久的镇痛效果,且成本更低、方法更简单。
60名计划接受MRM的女性参与了本研究。患者被随机分为两组,分别接受超声引导下的改良PECS阻滞(PECS组)或在手术伤口滴注镇痛药(局部滴注组)。在两组中,我们使用1mg/kg盐酸氯胺酮加0.25%盐酸布比卡因,总量为30mL。记录术后48小时内解救吗啡的总消耗量、首次镇痛需求时间、数字评分量表(NRS)、血流动力学效应。此外,记录执行每种技术所需的时间以及可能的副作用。
解救吗啡的总消耗量、首次镇痛需求、疼痛评分在两组中均无统计学显著差异;局部滴注操作所需时间在统计学上显著短于PECS操作。两组在不良反应发生率方面均无显著差异。
改良根治性乳房切除术后,局部伤口滴注提供了与PECS-II阻滞相当的镇痛效果。氯胺酮-布比卡因组合可延长镇痛时间近2天。